Pre-diabetes essential action: a European perspective - 17/02/08

Doi : DM-12-2005-31-6-1262-3636-101019-200516342

P Valensi^[1],
P Schwarz^[2],
M Hall^[3],
AM Felton^[4],
A Maldonato^[5],
C Mathieu^[6]
Mostrare le affiliazioni Nascondere le affiliazioni
^[1] Department of Endocrinology-Diabetology-Nutrition, Jean Verdier Hospital, Bondy, France
^[2] Medical Faculty Carl-Gustav — Carus of the Technical University Dresden, Medical Clinic III, Dresden, Germany
^[3] International Diabetes Federation (IDF), Brussels, Belgium
^[4] Chair Federation of European Nurses in Diabetes, London, UK
^[5] “La Sapienza” University, Diabetes Unit, St. Andrea Hospital, Roma, Italy
^[6] Department of Endocrinology, UZ Gasthuisberg, Leuven, Belgium

connettersi o creare un account

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

L'importance d'agir dans le pré-diabète: une perspective européenne

Pre-diabetes essential action: a European perspective

Mots clés : Pré-diabete , Intolérance au glucose , Hyperglycémie modérée à jeun , Obésité , Metformine , Acarbose , Mode de vie

Keywords: Prediabetes , Impaired glucose tolerance , Impaired fasting glucose , Obesity , Metformin , Acarbose , Lifestyle

Mappa

Riassunto

Introduction

A call for urgent action

Question 1: Can we agree on a definition of pre-diabetes? How does it relate to impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT)? And should we view it as a true disease or just a risk marker?

Answer

Question 2: What do we know about the pathophysiology of pre-diabetes?

Answer

Question 3: How prevalent is pre-diabetes in Europe and are we more likely to find it in specific “high risk” groups?

Question 4: Can we quantify the risk of pre-diabetes both in terms of diabetes and cardiovascular disease?

Answer

Cardiovascular risk

Question 5: What evidence have we that actively managing pre-diabetes is beneficial in preventing diabetes and or CVD?

Answer

Question 6: What strategies should we adopt to identify pre-diabetes?

Answer

Question 7: What screening tests could we use?

Answer

Question 8: How should we be managing pre-diabetes in clinical practice?

Answer

Question 9: How can diagnosis and management be organised to provide the highest quality care?

Answer

Question 10: How do we ensure that a diagnosis of pre-diabetes does not stigmatise these people?

Answer

Esportazione

Vol 31 - N° 6

P. 606-620 - dicembre 2005 Ritorno al numero

Articolo precedente

Factors associated with diabetic patients at high risk for foot ulceration
F Leymarie, JL Richard, D Malgrange

| Articolo seguente

Prevalence of mitochondrial A3243G mutation in adult type 1 diabetic patients in Catalonia
G Francisco, C Hernández, R Martínez, E García-Arumí, A Andreu, R Simó

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

connettersi o creare un account

Pre-diabetes essential action: a European perspective - 17/02/08

L'importance d'agir dans le pré-diabète: une perspective européenne

Pre-diabetes essential action: a European perspective

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL